Exploiting temozolomide-induced hypermutation with pembrolizumab in a refractory high-grade neuroendocrine neoplasm: A proof-of-concept case Journal Article

  

Authors:	Klempner, S. J.; Hendifar, A.; Waters, K. M.; Nissen, N.; Vail, E.; Tuli, R.; Mita, A.
Article Title:	Exploiting temozolomide-induced hypermutation with pembrolizumab in a refractory high-grade neuroendocrine neoplasm: A proof-of-concept case
Journal Title:	JCO Precision Oncology
Volume:	4
ISSN:	2473-4284
Publisher:	American Society of Clinical Oncology
Date Published:	2020-06-11
Start Page:	614
End Page:	619
Language:	English
DOI:	10.1200/po.20.00034
PROVIDER:	scopus
PUBMED:	35050748
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090710758&doi=10.1200%2fPO.20.00034&partnerID=40&md5=a33087714280443122fa8e29fc244f6e
Notes:	Article -- Export Date: 1 October 2020 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/171151